PARATEK PHARMACEUTICALS INC shareholders Q1 2023

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 65 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

PARATEK PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,971,241$5,006,9523.27%
AIGH Capital Management LLC 2,674,812$6,794,0232.50%
CM Management, LLC 450,000$1,1431.36%
Bruce & Co., Inc. 1,556,247$3,952,8671.08%
Worth Venture Partners, LLC 657,885$1,671,0280.82%
NEXPOINT ASSET MANAGEMENT, L.P. 2,495,770$6,339,2560.69%
GENERAL AMERICAN INVESTORS CO INC 1,914,424$4,862,6370.46%
Trellus Management Company, LLC 127,000$322,5800.38%
Eversept Partners, LP 638,474$1,621,7240.11%
PERKINS CAPITAL MANAGEMENT INC 45,700$1160.11%
Rock Springs Capital Management LP 1,734,037$4,404,4540.10%
J. Goldman & Co LP 915,501$2,325,3730.09%
Carlyle Group Inc. 1,041,131$2,623,6500.08%
Teton Advisors, Inc. 33,700$85,5980.02%
Kathmere Capital Management, LLC 30,000$76,2000.01%
Cutter & CO Brokerage, Inc. 10,900$27,6860.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 107,700$273,5580.01%
BROWN BROTHERS HARRIMAN & CO 287,902$731,2710.01%
Virtu Financial LLC 18,192$460.01%
WATER ISLAND CAPITAL LLC 13,050$330.00%
External links

This page lists PARATEK PHARMACEUTICALS INC's shareholders in Q1 2023. To view PARATEK PHARMACEUTICALS INC's shareholder history, click here.